Premium
This is an archive article published on April 9, 2019

Willing to pay Rs 25 lakh as compensation for faulty hip implants: J&J

The Delhi HC was hearing J&J’s plea challenging the Centre’s formula for the grant of compensation, including its recent decision directing the company to pay compensation of Rs 65 lakh and Rs 74 lakh to two affected patients.

johnson and johnson, hip implants, faulty hip implants, medical devices, patients, compensation, delhi high court, indian express news J&J, in its petition filed in December 2018, had challenged a press release issued by the Health Ministry, asking the company to pay compensation to affected patients as determined by the reports of two expert committees.

Global pharma giant Johnson and Johnson (J&J) on Monday told the Delhi High Court it is willing to pay Rs 25 lakh as compensation to patients who received faulty hip implants.

J&J however argued before Justice Vibhu Bakhru that the Centre has no jurisdiction under the Drugs and Cosmetics Act and Rules to fix and enforce the compensation. “Determination of compensation is the exclusive domain of the judiciary,” the counsel for J&J submitted.

On hearing the argument, the court issued a notice to the Centre and directed the ministry concerned to take instruction by May 2. It also orally asked them not to take any steps against J&J.

Story continues below this ad

The HC was hearing J&J’s plea challenging the Centre’s formula for the grant of compensation, including its recent decision directing the company to pay compensation of Rs 65 lakh and Rs 74 lakh to two affected patients.

J&J, in its petition filed in December 2018, had challenged a press release issued by the Health Ministry, asking the company to pay compensation to affected patients as determined by the reports of two expert committees formed to examine the issues relating to its faulty hip implants.

The two committees were formed under Dr Arun Kumar Agarwal, former dean and professor of ENT at Maulana Azad Medical College, New Delhi, and Dr R K Arya, director, Sports Injury Centre. While the Agarwal Committee examined the issues relating to faulty Articular Surface Replacement (ASR) hip implants, the Arya committee determined the quantum of compensation.

The compensation formula is based on the percentage of disability, age factor, and risk factor, and was accepted by the government, as per a press release issued on November 29, 2018. Applying the formula, the patients would get as much as Rs 1.2 crore each and an additional Rs 10 lakh for “non-pecuniary” losses.

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Loading Taboola...
Advertisement